Final appraisal determination
Equalities impact assessment
Melanoma (metastatic) - talimogene laherparepvec: draft scope for consultation (pre-referral) - November 2014
Melanoma (metastatic) - talimogene laherparepvec: provisional matrix (pre-referral) - November 2014